CTMX vs. CMPX

Last updated Jun 4, 2026

CTMX (CytomX Therapeutics, Inc.) and CMPX (Compass Therapeutics Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, CTMX returned -13.81%/yr vs -17.21%/yr for CMPX. At a 0.20 correlation, their price movements are largely independent.

Performance

CTMX vs. CMPX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CytomX Therapeutics, Inc. (CTMX) and Compass Therapeutics Inc. (CMPX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CTMX achieves a -24.41% return, which is significantly higher than CMPX's -60.89% return.

CTMX

• 1D: 1.90%
• 1M: -22.97%
• YTD: -24.41%
• 6M: -19.50%
• 1Y: 21.51%
• 3Y*: 23.01%
• 5Y*: -13.81%
• 10Y*: -11.44%

CMPX

• 1D: 0.96%
• 1M: 8.25%
• YTD: -60.89%
• 6M: -60.23%
• 1Y: -1.87%
• 3Y*: -10.66%
• 5Y*: -17.21%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CTMX vs. CMPX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CTMX CytomX Therapeutics, Inc.	-24.41%	313.59%	-33.55%	-3.13%	-63.05%	-48.33%
CMPX Compass Therapeutics Inc.	-60.89%	270.34%	-7.05%	-68.99%	58.68%	-62.71%

Correlation

The correlation between CTMX and CMPX is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.23
Correlation (3Y) Calculated over the trailing 3-year period	0.25
Correlation (5Y) Calculated over the trailing 5-year period	0.21
Correlation (All Time) Calculated using the full available price history since Apr 6, 2021	0.20

Fundamentals

Market Cap CTMX : $570.82M CMPX : $391.44M
EPS CTMX : -$0.37 CMPX : -$0.42
PB Ratio CTMX : 1.78 CMPX : 2.10
Total Revenue (TTM) CTMX : $35.54M CMPX : $0.00
Gross Profit (TTM) CTMX : $24.77M CMPX : -$370.00K
EBITDA (TTM) CTMX : -$62.07M CMPX : -$72.86M

Return for Risk

CTMX vs. CMPX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CTMX

CTMX Risk / Return Rank: 52
CTMX Sharpe Ratio Rank: 49
CTMX Sortino Ratio Rank: 56
CTMX Omega Ratio Rank: 55
CTMX Calmar Ratio Rank: 50
CTMX Martin Ratio Rank: 51

CMPX

CMPX Risk / Return Rank: 45
CMPX Sharpe Ratio Rank: 41
CMPX Sortino Ratio Rank: 49
CMPX Omega Ratio Rank: 57
CMPX Calmar Ratio Rank: 40
CMPX Martin Ratio Rank: 39

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CTMX vs. CMPX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CytomX Therapeutics, Inc. (CTMX) and Compass Therapeutics Inc. (CMPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CTMX	CMPX	Difference
Sharpe ratio Return per unit of total volatility	0.22	-0.02	+0.24
Sortino ratio Return per unit of downside risk	1.11	0.79	+0.32
Omega ratio Gain probability vs. loss probability	1.14	1.15	-0.01
Calmar ratio Return relative to maximum drawdown	0.41	-0.03	+0.43
Martin ratio Return relative to average drawdown	0.91	-0.07	+0.98
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CTMX vs. CMPX - Sharpe Ratio Comparison

The current CTMX Sharpe Ratio is 0.22, which is higher than the CMPX Sharpe Ratio of -0.02. The chart below compares the historical Sharpe Ratios of CTMX and CMPX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CTMX	CMPX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.22	-0.02	+0.24
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.10	-0.20	+0.10
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.10	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.11	-0.27	+0.16

Drawdowns

CTMX vs. CMPX - Drawdown Comparison

The maximum CTMX drawdown since its inception was -98.74%, which is greater than CMPX's maximum drawdown of -90.91%. Use the drawdown chart below to compare losses from any high point for CTMX and CMPX.

Drawdown Indicators

	CTMX	CMPX	Difference
Max Drawdown Largest peak-to-trough decline	-98.74%	-90.91%	-7.83%
Max Drawdown (1Y) Largest decline over 1 year	-53.19%	-75.04%	+21.85%
Max Drawdown (3Y) Largest decline over 3 years	-91.59%	-76.47%	-15.12%
Max Drawdown (5Y) Largest decline over 5 years	-94.16%	-85.53%	-8.63%
Max Drawdown (10Y) Largest decline over 10 years	-98.74%	—	—
Current Drawdown Current decline from peak	-90.59%	-76.14%	-14.45%
Average Drawdown Average peak-to-trough decline	-70.69%	-65.74%	-4.95%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.71%	25.45%	-1.74%

Volatility

CTMX vs. CMPX - Volatility Comparison

The current volatility for CytomX Therapeutics, Inc. (CTMX) is 13.80%, while Compass Therapeutics Inc. (CMPX) has a volatility of 19.17%. This indicates that CTMX experiences smaller price fluctuations and is considered to be less risky than CMPX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CTMX	CMPX	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.80%	19.17%	-5.37%
Volatility (6M) Calculated over the trailing 6-month period	68.42%	112.72%	-44.30%
Volatility (1Y) Calculated over the trailing 1-year period	96.69%	94.04%	+2.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	141.79%	87.05%	+54.74%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	111.36%	88.40%	+22.96%

Dividends

CTMX vs. CMPX - Dividend Comparison

Neither CTMX nor CMPX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CTMX and CMPX in my portfolio?

CTMX and CMPX have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CTMX or CMPX?

CMPX has higher volatility (19.17%) compared to CTMX (13.80%). In terms of maximum drawdown, CTMX dropped -98.74% vs CMPX's -90.91%.

Which has better risk-adjusted returns?

CTMX currently has the higher Sharpe Ratio (0.22 vs -0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.